MARC details
| 000 -LÍDER |
|---|
| fixed length control field |
05330nam a22004335i 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| control field |
u377276 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| control field |
SIRSI |
| 005 - FECHA Y HORA DE LA ULTIMA TRANSACCIÓN |
|---|
| control field |
20160812084454.0 |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FIJA--INFORMACIÓN GENERAL |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - ELEMENTOS DE LONGITUD FIJA -- INFORMACIÓN GENERAL |
|---|
| fixed length control field |
101002s2010 it | s |||| 0|eng d |
| 020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
|---|
| International Standard Book Number |
9788847014633 |
| -- |
978-88-470-1463-3 |
| 040 ## - FUENTE DE CATALOGACIÓN |
|---|
| Transcribing agency |
MX-MeUAM |
| 050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Classification number |
RC681-688.2 |
| 082 04 - NÚMERO DE CLASIFICACIÓN DECIMAL DEWEY |
|---|
| Classification number |
616.12 |
| Edition number |
23 |
| 100 1# - ASIENTO PRINCIPAL--NOMBRE PERSONAL |
|---|
| Personal name |
Berbari, Adel E. |
| Relator term |
editor. |
| 245 10 - MENCIÓN DE TITULO |
|---|
| Title |
Cardiorenal Syndrome |
| Medium |
[recurso electrónico] : |
| Remainder of title |
Mechanisms, Risk and Treatment / |
| Statement of responsibility, etc. |
edited by Adel E. Berbari, Giuseppe Mancia. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Milano : |
| Name of producer, publisher, distributor, manufacturer |
Springer Milan, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2010. |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extent |
XV, 396 p. |
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - NOTA DE CONTENIDO |
|---|
| Formatted contents note |
Chronic Kidney Disease and Cardiovascular Disease Interrelationships -- Links between Chronic Kidney Disease and Cardiovascular Disease: A Bidirectional Relationship -- Cardiorenal versus Renocardiac Syndrome -- Crosstalk between the Cardiovascular System and the Kidney -- Non-Pressure-Related Deleterious Effects of Excessive Dietary Sodium -- Regulation of Vascular and Renal Cells by Common Mediators in Health and Disease: Role of the Renin—Angiotensin System in the Pathophysiology of Hypertension and Cardiovascular Disease -- Chronic Kidney Disease as a Risk for Cardiovascular Disease -- Cardiorenal Continuum -- Definition and Classification of Stages of Chronic Kidney Disease: Screening for Chronic Kidney Disease -- Cardiovascular Disease Risk Factors in Chronic Kidney Disease: Traditional, Nontraditional, and Uremia-related Threats -- Increased Levels of Urinary Albumin: A Cardiovascular Risk Factor and a Target for Treatment -- Microalbuminuria and Kidney Disease: An Evidence-based Perspective -- Cardiometabolic Syndrome -- Diabetes Mellitus: Is the Presence of Nephropathy Important as a Cardiovascular Risk Factor for Cardioneral Syndrome? -- Spectrum of Cardiovascular Disease in Chronic Kidney Disease -- Cardiovascular Disease: Coronary Artery Disease and Coronary Artery Calcification -- Cardiomyopathy in Chronic Kidney Disease and in End-stage Renal Disease -- Pathophysiological Mechanisms and Prognostic Significance of Renal Functional Impairment in Cardiac Patients -- Stroke -- Mechanisms of Cardiovascular Complications -- Uremic Toxins -- Endothelial Dysfunction, Nitric Oxide Bioavailability, and Asymmetric Dimethyl Arginine -- Pathophysiologic Link between Atherosclerosis and Nephrosclerosis -- Aortic Stiffness, Kidney Disease, and Renal Transplantation -- Disturbed Calcium-Phosphorus Metabolism/Arterial Calcifications: Consequences on Cardiovascular Function and Clinical Outcome -- Role of Neurohormonal Activation in the Pathogenesis of Cardiovascular Complications in Chronic Kidney Disease -- Impaired Autonomic Blood Pressure and Blood Volume Control in Chronic Renal Failure -- Role of Novel Biomarkers in Chronic Kidney Disease: Urotensin II -- Role of Novel Biomarkers in Chronic Kidney Disease: Renalase -- Regression/Progression of Chronic Kidney Disease -- Diabetic Kidney Disease -- Nondiabetic Kidney Disease -- Therapeutic Modalities -- Approaches in the Management of Patients with Chronic Kidney Disease and Cardiovascular Disease -- Trends in the Management of Cardiac Patients with Renal Functional Impairment. |
| 520 ## - NOTA DE RESUMEN, ETC. |
|---|
| Summary, etc. |
Accelerated cardiovascular disease is a frequent complication of chronic kidney disease. Individuals with evidence of renal functional impairment are more likely to die of cardiovascular events than to progress to end stage renal disease. This relationship, which has been termed the cardiorenal syndrome, exists whether impairment of renal function is a consequence of primary renal parenchymal or primary heart disease. The mechanisms underlying the cardiorenal syndrome result from a complex interaction of traditional and uremia related cardiovascular risk factors. Prevention and management of cardiovascular disease include aggressive control of traditional risk factors as well novel approach to prevent or reverse uremia related processes. Chronic kidney disease with a worldwide prevalence of 10% in the general population is emerging as a major public health priority. Renal dysfunction is associated with a high risk for cardiovascular complications. The relationship between renal insufficiency and cardiovascular disease, termed the cardiorenal syndrome exists whether impairment of renal function is a consequence of primary renal parenchymal disease or primary heart disease. This book provides a comprehensive update analysis of our current understanding of the cardiorenal syndrome, including epidemiology, pathophysiologic mechanisms, and therapeutic approaches. |
| 596 ## - |
|---|
| -- |
19 |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Medicine. |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Cardiology. |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Nephrology. |
| 650 14 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Medicine & Public Health. |
| 650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Cardiology. |
| 650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Nephrology. |
| 700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL |
|---|
| Personal name |
Mancia, Giuseppe. |
| Relator term |
editor. |
| 710 2# - ASIENTO SECUNDARIO - NOMBRE CORPORATIVO |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9788847014626 |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Public note |
Libro electrónico |
| Uniform Resource Identifier |
<a href="http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-88-470-1463-3">http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-88-470-1463-3</a> |
| 942 ## - TIPO DE MATERIAL (KOHA) |
|---|
| Koha item type |
Libro Electrónico |
